全球凍乾注射劑市場研究報告 - 2023 年至 2030 年行業分析、規模、佔有率、成長、趨勢和預測

全球凍乾注射劑市場需求預計將從 2022 年的 69.3 億美元增至 2030 年的近 137.3 億美元，2023-2030 年研究期間複合年成長率為 8.92%。

凍乾注射劑是凍乾藥物，在運輸過程中保持穩定。凍乾注射劑是使用凍乾工藝生產的，該工藝涉及在真空下冷凍和蒸發溶液，以從溶劑中分離出固體物質。凍乾注射劑被認為是口服具體劑型的最有效替代品。臥床不起的人從凍乾注射劑中受益匪淺。凍乾注射劑還可以為患有各種疾病的患者提供最大程度的吸收和穩定性，因為它們的保存期限比其他劑量更長。

市場動態

推動凍乾注射劑市場成長的重要因素是對契約研究製造服務的需求增加和藥品核准的增加。凍乾注射藥物的不斷進步的技術進步可能會推動凍乾注射藥物的成長。對凍乾藥物的監管批准增加可能會刺激對凍乾注射藥物的需求。凍乾藥品召回數量和包裝類型的增加預計將限制凍乾注射劑市場。與注射產品凍乾瓶生產相關的因素可能對這些藥物構成挑戰，限制市場成長。

該研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球凍乾注射劑市場的每個細分市場進行了包容性評估。凍乾注射劑行業的成長和趨勢為本研究提供了整體方法。

市場細分

凍乾注射劑市場報告的這一部分提供了國家和區域層面細分市場的詳細數據，從而幫助戰略家確定相應產品或服務的目標人群以及即將到來的機會。

按包裝

• 拋棄式小瓶
• 照護端重構
• 專業包裝

送貨方式

• 預裝稀釋劑注射器
• 專有的重構設備
• 單步設備
• 多步設備

按指示

• 自身免疫性疾病
• 傳染性疾病
• 代謝狀況
• 其他

按最終用戶

• 醫院
• 門診手術中心
• 專科診所
• 其他
• 區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲凍乾注射劑市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。凍乾注射劑市場的主要參與者包括 B. Braun Melsungen AG、Baxter International Inc.、BD、Schott AG、Aristopharma Ltd.、Vetter Pharma、Jubilant HollisterStier LLC。本節包含競爭格局的整體視圖，包括各種戰略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第一章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：凍乾注射劑 - 行業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 行業動態
• 波特五力分析
• 市場吸引力分析
  • 按包裝進行的市場吸引力分析
  • 按交付進行的市場吸引力分析
  • 按指標進行的市場吸引力分析
  • 最終用戶的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷管道發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球凍乾注射劑市場分析：按包裝分類

• 按包裝概述
• 歷史和預測數據
• 按包裝分析
• 拋棄式小瓶
• 現場護理重構
• 專業包裝

第 7 章：全球凍乾注射劑市場分析：按交付方式

• 按交付概覽
• 歷史和預測數據
• 按交付分析
• 預裝稀釋劑注射器
• 專有的重構設備
• 單步設備
• 多步裝置

第 8 章：全球凍乾注射劑市場分析：按適應症分類

• 按適應症概述
• 歷史和預測數據
• 按指標分析
• 自身免疫性疾病
• 傳染性疾病
• 代謝狀況
• 其他

第 9 章：全球凍乾注射劑市場分析：按最終用戶分類

• 最終用戶概述
• 歷史和預測數據
• 最終用戶分析
• 醫院
• 門診手術中心
• 專科診所
• 其他

第 10 章：全球凍乾注射劑市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概述、歷史和預測銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家/地區銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概述、歷史和預測銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家/地區銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概述、歷史和預測銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳大利亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概述、歷史和預測銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家/地區銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概述、歷史和預測銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 11 章：凍乾注射劑公司的競爭格局

• 凍乾注射劑市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 12 章：公司簡介

• 頂級公司股票分析
• 市場集中度
• B. Braun Melsungen AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Baxter International Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• BD
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Schott AG
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Aristopharma Ltd.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Vetter Pharma
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Jubilant HollisterStier LLC
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私營公司，則可能不包括在內

The global demand for Lyophilized Injectable Market is presumed to reach the market size of nearly USD 13.73 BN by 2030 from USD 6.93 BN in 2022 with a CAGR of 8.92% under the study period 2023 - 2030.

Lyophilized injectables are freeze-dried medications that remain stable during transportation. Lyophilized injectables are created using the lyophilization process, which involves freezing and evaporating a solution under a vacuum to isolate a solid substance from a solvent. Lyophilized injectables are regarded as the most effective alternative to oral concrete dose forms. Bedridden individuals have greatly benefited from lyophilized injectables. Lyophilized injectables also provide maximum absorption and stability in patients suffering from various disorders since they have a longer shelf life than other doses.

MARKET DYNAMICS:

The vital factors driving the growth of the lyophilized injectables market are increased demand for contract research manufacturing services and rising pharmaceutical approvals. The increasing technological improvements in lyophilized injectable medications will likely fuel the growth of lyophilized injectable drugs. The increased regulatory approvals for lyophilized pharmaceuticals will likely stimulate demand for lyophilized injectable medications. The increase in the number of lyophilized medication product recalls and packaging types are projected to restrict the lyophilized injectable market. Factors related to the production of lyophilized vials for injectable products likely pose a challenge for these medications limiting the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lyophilized injectable. The growth and trends of lyophilized injectable industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the lyophilized injectable market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Packaging

• Single-Use Vials
• Point-Of-Care Reconstitution
• Specialty Packaging

By Delivery

• Prefilled Diluent Syringes
• Proprietary Reconstitution Devices
• Single-Step Devices
• Multi-Step Devices

By Indication

• Autoimmune Diseases
• Infectious Diseases
• Metabolic Conditions
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Lyophilized Injectable market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lyophilized injectable market include B. Braun Melsungen AG, Baxter International Inc., BD, Schott AG, Aristopharma Ltd., Vetter Pharma, Jubilant HollisterStier LLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . LYOPHILIZED INJECTABLE - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Packaging
  • 3.7.2 Market Attractiveness Analysis By Delivery
  • 3.7.3 Market Attractiveness Analysis By Indication
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY PACKAGING

• 6.1 Overview by Packaging
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Packaging
• 6.4 Single-use Vials Historic and Forecast Sales by Regions
• 6.5 Point-of-care Reconstitution Historic and Forecast Sales by Regions
• 6.6 Specialty Packaging Historic and Forecast Sales by Regions

7 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY DELIVERY

• 7.1 Overview by Delivery
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Delivery
• 7.4 Prefilled Diluent Syringes Historic and Forecast Sales by Regions
• 7.5 Proprietary Reconstitution Devices Historic and Forecast Sales by Regions
• 7.6 Single-step Devices Historic and Forecast Sales by Regions
• 7.7 Multi-step Devices Historic and Forecast Sales by Regions

8 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY INDICATION

• 8.1 Overview by Indication
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Indication
• 8.4 Autoimmune Diseases Historic and Forecast Sales by Regions
• 8.5 Infectious Diseases Historic and Forecast Sales by Regions
• 8.6 Metabolic Conditions Historic and Forecast Sales by Regions
• 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY END USER

• 9.1 Overview by End User
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End User
• 9.4 Hospitals Historic and Forecast Sales by Regions
• 9.5 Ambulatory Surgical Centers Historic and Forecast Sales by Regions
• 9.6 Specialty Clinics Historic and Forecast Sales by Regions
• 9.7 Others Historic and Forecast Sales by Regions

10 . GLOBAL LYOPHILIZED INJECTABLE MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE LYOPHILIZED INJECTABLE COMPANIES

• 11.1. Lyophilized Injectable Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF LYOPHILIZED INJECTABLE INDUSTRY

• 12.1. Top Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. B. Braun Melsungen AG
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. Baxter International Inc.
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. BD
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. Schott AG
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Aristopharma Ltd.
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. Vetter Pharma
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. Jubilant HollisterStier LLC
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Packaging (USD MN)
• Single-use Vials Market Sales by Geography (USD MN)
• Point-of-care Reconstitution Market Sales by Geography (USD MN)
• Specialty Packaging Market Sales by Geography (USD MN)
• Analysis Market by Delivery (USD MN)
• Prefilled Diluent Syringes Market Sales by Geography (USD MN)
• Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
• Single-step Devices Market Sales by Geography (USD MN)
• Multi-step Devices Market Sales by Geography (USD MN)
• Analysis by Indication (USD MN)
• Autoimmune Diseases Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Metabolic Conditions Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Lyophilized Injectable Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Lyophilized Injectable Report
• Market Research Process
• Market Research Methodology
• Global Lyophilized Injectable Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Packaging
• Market Attractiveness Analysis by Delivery
• Market Attractiveness Analysis by Indication
• Market Attractiveness Analysis by End User
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Packaging (USD MN)
• Single-use Vials Market Sales by Geography (USD MN)
• Point-of-care Reconstitution Market Sales by Geography (USD MN)
• Specialty Packaging Market Sales by Geography (USD MN)
• Global Market Analysis by Delivery (USD MN)
• Prefilled Diluent Syringes Market Sales by Geography (USD MN)
• Proprietary Reconstitution Devices Market Sales by Geography (USD MN)
• Single-step Devices Market Sales by Geography (USD MN)
• Multi-step Devices Market Sales by Geography (USD MN)
• Global Market Analysis by Indication (USD MN)
• Autoimmune Diseases Market Sales by Geography (USD MN)
• Infectious Diseases Market Sales by Geography (USD MN)
• Metabolic Conditions Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End User (USD MN)
• Hospitals Market Sales by Geography (USD MN)
• Ambulatory Surgical Centers Market Sales by Geography (USD MN)
• Specialty Clinics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.